Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
Market Analysis and Insights: Global Remicade Biosimilar Market
Prior to COVID-19, the market for Remicade Biosimilar was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Remicade Biosimilar is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Remicade Biosimilar market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Remicade Biosimilar market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Remicade Biosimilar industry.
Global Remicade Biosimilar Scope and Segment
Remicade Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Remicade Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Remicade Biosimilar Breakdown Data by Type
100mg/10ml
500mg/50ml
Remicade Biosimilar Breakdown Data by Application
Blood Disorders
Oncology Diseases
Regional and Country-level Analysis
The Remicade Biosimilar market is analysed and market size information is provided by regions (countries).
The key regions covered in the Remicade Biosimilar market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Remicade Biosimilar Market Share Analysis
Market Analysis and Insights: Global Remicade Biosimilar Market
Prior to COVID-19, the market for Remicade Biosimilar was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Remicade Biosimilar is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Remicade Biosimilar market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Remicade Biosimilar market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Remicade Biosimilar industry.
Global Remicade Biosimilar Scope and Segment
Remicade Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Remicade Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Remicade Biosimilar Breakdown Data by Type
100mg/10ml
500mg/50ml
Remicade Biosimilar Breakdown Data by Application
Blood Disorders
Oncology Diseases
Regional and Country-level Analysis
The Remicade Biosimilar market is analysed and market size information is provided by regions (countries).
The key regions covered in the Remicade Biosimilar market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Remicade Biosimilar Market Share Analysis
1 Study Coverage
1.1 Remicade Biosimilar Product Introduction
1.2 Market Segments
1.3 Key Remicade Biosimilar Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Remicade Biosimilar Market Size Growth Rate by Type
1.4.2 100mg/10ml
1.4.3 500mg/50ml
1.5 Market by Application
1.5.1 Global Remicade Biosimilar Market Size Growth Rate by Application
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Remicade Biosimilar Market Size, Estimates and Forecasts
2.1.1 Global Remicade Biosimilar Revenue 2015-2026
2.1.2 Global Remicade Biosimilar Sales 2015-2026
2.2 Global Remicade Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Remicade Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Remicade Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Remicade Biosimilar Competitor Landscape by Players
3.1 Remicade Biosimilar Sales by Manufacturers
3.1.1 Remicade Biosimilar Sales by Manufacturers (2015-2020)
3.1.2 Remicade Biosimilar Sales Market Share by Manufacturers (2015-2020)
3.2 Remicade Biosimilar Revenue by Manufacturers
3.2.1 Remicade Biosimilar Revenue by Manufacturers (2015-2020)
3.2.2 Remicade Biosimilar Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Remicade Biosimilar Revenue in 2019
3.2.5 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Remicade Biosimilar Price by Manufacturers
3.4 Remicade Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Remicade Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Remicade Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Remicade Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Remicade Biosimilar Market Size by Type (2015-2020)
4.1.1 Global Remicade Biosimilar Sales by Type (2015-2020)
4.1.2 Global Remicade Biosimilar Revenue by Type (2015-2020)
4.1.3 Remicade Biosimilar Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Remicade Biosimilar Market Size Forecast by Type (2021-2026)
4.2.1 Global Remicade Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Remicade Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Remicade Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Remicade Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Remicade Biosimilar Market Size by Application (2015-2020)
5.1.1 Global Remicade Biosimilar Sales by Application (2015-2020)
5.1.2 Global Remicade Biosimilar Revenue by Application (2015-2020)
5.1.3 Remicade Biosimilar Price by Application (2015-2020)
5.2 Remicade Biosimilar Market Size Forecast by Application (2021-2026)
5.2.1 Global Remicade Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Remicade Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Remicade Biosimilar Price Forecast by Application (2021-2026)
6 North America
6.1 North America Remicade Biosimilar by Country
6.1.1 North America Remicade Biosimilar Sales by Country
6.1.2 North America Remicade Biosimilar Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Remicade Biosimilar Market Facts & Figures by Type
6.3 North America Remicade Biosimilar Market Facts & Figures by Application
7 Europe
7.1 Europe Remicade Biosimilar by Country
7.1.1 Europe Remicade Biosimilar Sales by Country
7.1.2 Europe Remicade Biosimilar Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Remicade Biosimilar Market Facts & Figures by Type
7.3 Europe Remicade Biosimilar Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Remicade Biosimilar by Region
8.1.1 Asia Pacific Remicade Biosimilar Sales by Region
8.1.2 Asia Pacific Remicade Biosimilar Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Remicade Biosimilar Market Facts & Figures by Type
8.3 Asia Pacific Remicade Biosimilar Market Facts & Figures by Application
9 Latin America
9.1 Latin America Remicade Biosimilar by Country
9.1.1 Latin America Remicade Biosimilar Sales by Country
9.1.2 Latin America Remicade Biosimilar Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Remicade Biosimilar Market Facts & Figures by Type
9.3 Central & South America Remicade Biosimilar Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Remicade Biosimilar by Country
10.1.1 Middle East and Africa Remicade Biosimilar Sales by Country
10.1.2 Middle East and Africa Remicade Biosimilar Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Type
10.3 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Application
11 Company Profiles
11.1 Synthon Pharmaceuticals
11.1.1 Synthon Pharmaceuticals Corporation Information
11.1.2 Synthon Pharmaceuticals Description and Business Overview
11.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
11.1.5 Synthon Pharmaceuticals Related Developments
11.2 LG Life Sciences
11.2.1 LG Life Sciences Corporation Information
11.2.2 LG Life Sciences Description and Business Overview
11.2.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 LG Life Sciences Remicade Biosimilar Products Offered
11.2.5 LG Life Sciences Related Developments
11.3 Novartis (Sandoz)
11.3.1 Novartis (Sandoz) Corporation Information
11.3.2 Novartis (Sandoz) Description and Business Overview
11.3.3 Novartis (Sandoz) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered
11.3.5 Novartis (Sandoz) Related Developments
11.4 Celltrion
11.4.1 Celltrion Corporation Information
11.4.2 Celltrion Description and Business Overview
11.4.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celltrion Remicade Biosimilar Products Offered
11.4.5 Celltrion Related Developments
11.5 Biocon
11.5.1 Biocon Corporation Information
11.5.2 Biocon Description and Business Overview
11.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biocon Remicade Biosimilar Products Offered
11.5.5 Biocon Related Developments
11.6 Hospira
11.6.1 Hospira Corporation Information
11.6.2 Hospira Description and Business Overview
11.6.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Hospira Remicade Biosimilar Products Offered
11.6.5 Hospira Related Developments
11.7 Merck Serono (Merck Group)
11.7.1 Merck Serono (Merck Group) Corporation Information
11.7.2 Merck Serono (Merck Group) Description and Business Overview
11.7.3 Merck Serono (Merck Group) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered
11.7.5 Merck Serono (Merck Group) Related Developments
11.8 Biogen idec Inc.
11.8.1 Biogen idec Inc. Corporation Information
11.8.2 Biogen idec Inc. Description and Business Overview
11.8.3 Biogen idec Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered
11.8.5 Biogen idec Inc. Related Developments
11.9 Genentech (Roche Group)
11.9.1 Genentech (Roche Group) Corporation Information
11.9.2 Genentech (Roche Group) Description and Business Overview
11.9.3 Genentech (Roche Group) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered
11.9.5 Genentech (Roche Group) Related Developments
11.1 Synthon Pharmaceuticals
11.1.1 Synthon Pharmaceuticals Corporation Information
11.1.2 Synthon Pharmaceuticals Description and Business Overview
11.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
11.1.5 Synthon Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Remicade Biosimilar Market Estimates and Projections by Region
12.1.1 Global Remicade Biosimilar Sales Forecast by Regions 2021-2026
12.1.2 Global Remicade Biosimilar Revenue Forecast by Regions 2021-2026
12.2 North America Remicade Biosimilar Market Size Forecast (2021-2026)
12.2.1 North America: Remicade Biosimilar Sales Forecast (2021-2026)
12.2.2 North America: Remicade Biosimilar Revenue Forecast (2021-2026)
12.2.3 North America: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
12.3 Europe Remicade Biosimilar Market Size Forecast (2021-2026)
12.3.1 Europe: Remicade Biosimilar Sales Forecast (2021-2026)
12.3.2 Europe: Remicade Biosimilar Revenue Forecast (2021-2026)
12.3.3 Europe: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Remicade Biosimilar Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Remicade Biosimilar Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Remicade Biosimilar Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Remicade Biosimilar Market Size Forecast by Region (2021-2026)
12.5 Latin America Remicade Biosimilar Market Size Forecast (2021-2026)
12.5.1 Latin America: Remicade Biosimilar Sales Forecast (2021-2026)
12.5.2 Latin America: Remicade Biosimilar Revenue Forecast (2021-2026)
12.5.3 Latin America: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Remicade Biosimilar Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Remicade Biosimilar Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Remicade Biosimilar Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Remicade Biosimilar Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Remicade Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1.1 Remicade Biosimilar Product Introduction
1.2 Market Segments
1.3 Key Remicade Biosimilar Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Remicade Biosimilar Market Size Growth Rate by Type
1.4.2 100mg/10ml
1.4.3 500mg/50ml
1.5 Market by Application
1.5.1 Global Remicade Biosimilar Market Size Growth Rate by Application
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Remicade Biosimilar Market Size, Estimates and Forecasts
2.1.1 Global Remicade Biosimilar Revenue 2015-2026
2.1.2 Global Remicade Biosimilar Sales 2015-2026
2.2 Global Remicade Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Remicade Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Remicade Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Remicade Biosimilar Competitor Landscape by Players
3.1 Remicade Biosimilar Sales by Manufacturers
3.1.1 Remicade Biosimilar Sales by Manufacturers (2015-2020)
3.1.2 Remicade Biosimilar Sales Market Share by Manufacturers (2015-2020)
3.2 Remicade Biosimilar Revenue by Manufacturers
3.2.1 Remicade Biosimilar Revenue by Manufacturers (2015-2020)
3.2.2 Remicade Biosimilar Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Remicade Biosimilar Revenue in 2019
3.2.5 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Remicade Biosimilar Price by Manufacturers
3.4 Remicade Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Remicade Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Remicade Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Remicade Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Remicade Biosimilar Market Size by Type (2015-2020)
4.1.1 Global Remicade Biosimilar Sales by Type (2015-2020)
4.1.2 Global Remicade Biosimilar Revenue by Type (2015-2020)
4.1.3 Remicade Biosimilar Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Remicade Biosimilar Market Size Forecast by Type (2021-2026)
4.2.1 Global Remicade Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Remicade Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Remicade Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Remicade Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Remicade Biosimilar Market Size by Application (2015-2020)
5.1.1 Global Remicade Biosimilar Sales by Application (2015-2020)
5.1.2 Global Remicade Biosimilar Revenue by Application (2015-2020)
5.1.3 Remicade Biosimilar Price by Application (2015-2020)
5.2 Remicade Biosimilar Market Size Forecast by Application (2021-2026)
5.2.1 Global Remicade Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Remicade Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Remicade Biosimilar Price Forecast by Application (2021-2026)
6 North America
6.1 North America Remicade Biosimilar by Country
6.1.1 North America Remicade Biosimilar Sales by Country
6.1.2 North America Remicade Biosimilar Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Remicade Biosimilar Market Facts & Figures by Type
6.3 North America Remicade Biosimilar Market Facts & Figures by Application
7 Europe
7.1 Europe Remicade Biosimilar by Country
7.1.1 Europe Remicade Biosimilar Sales by Country
7.1.2 Europe Remicade Biosimilar Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Remicade Biosimilar Market Facts & Figures by Type
7.3 Europe Remicade Biosimilar Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Remicade Biosimilar by Region
8.1.1 Asia Pacific Remicade Biosimilar Sales by Region
8.1.2 Asia Pacific Remicade Biosimilar Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Remicade Biosimilar Market Facts & Figures by Type
8.3 Asia Pacific Remicade Biosimilar Market Facts & Figures by Application
9 Latin America
9.1 Latin America Remicade Biosimilar by Country
9.1.1 Latin America Remicade Biosimilar Sales by Country
9.1.2 Latin America Remicade Biosimilar Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Remicade Biosimilar Market Facts & Figures by Type
9.3 Central & South America Remicade Biosimilar Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Remicade Biosimilar by Country
10.1.1 Middle East and Africa Remicade Biosimilar Sales by Country
10.1.2 Middle East and Africa Remicade Biosimilar Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Type
10.3 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Application
11 Company Profiles
11.1 Synthon Pharmaceuticals
11.1.1 Synthon Pharmaceuticals Corporation Information
11.1.2 Synthon Pharmaceuticals Description and Business Overview
11.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
11.1.5 Synthon Pharmaceuticals Related Developments
11.2 LG Life Sciences
11.2.1 LG Life Sciences Corporation Information
11.2.2 LG Life Sciences Description and Business Overview
11.2.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 LG Life Sciences Remicade Biosimilar Products Offered
11.2.5 LG Life Sciences Related Developments
11.3 Novartis (Sandoz)
11.3.1 Novartis (Sandoz) Corporation Information
11.3.2 Novartis (Sandoz) Description and Business Overview
11.3.3 Novartis (Sandoz) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered
11.3.5 Novartis (Sandoz) Related Developments
11.4 Celltrion
11.4.1 Celltrion Corporation Information
11.4.2 Celltrion Description and Business Overview
11.4.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celltrion Remicade Biosimilar Products Offered
11.4.5 Celltrion Related Developments
11.5 Biocon
11.5.1 Biocon Corporation Information
11.5.2 Biocon Description and Business Overview
11.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biocon Remicade Biosimilar Products Offered
11.5.5 Biocon Related Developments
11.6 Hospira
11.6.1 Hospira Corporation Information
11.6.2 Hospira Description and Business Overview
11.6.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Hospira Remicade Biosimilar Products Offered
11.6.5 Hospira Related Developments
11.7 Merck Serono (Merck Group)
11.7.1 Merck Serono (Merck Group) Corporation Information
11.7.2 Merck Serono (Merck Group) Description and Business Overview
11.7.3 Merck Serono (Merck Group) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered
11.7.5 Merck Serono (Merck Group) Related Developments
11.8 Biogen idec Inc.
11.8.1 Biogen idec Inc. Corporation Information
11.8.2 Biogen idec Inc. Description and Business Overview
11.8.3 Biogen idec Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered
11.8.5 Biogen idec Inc. Related Developments
11.9 Genentech (Roche Group)
11.9.1 Genentech (Roche Group) Corporation Information
11.9.2 Genentech (Roche Group) Description and Business Overview
11.9.3 Genentech (Roche Group) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered
11.9.5 Genentech (Roche Group) Related Developments
11.1 Synthon Pharmaceuticals
11.1.1 Synthon Pharmaceuticals Corporation Information
11.1.2 Synthon Pharmaceuticals Description and Business Overview
11.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
11.1.5 Synthon Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Remicade Biosimilar Market Estimates and Projections by Region
12.1.1 Global Remicade Biosimilar Sales Forecast by Regions 2021-2026
12.1.2 Global Remicade Biosimilar Revenue Forecast by Regions 2021-2026
12.2 North America Remicade Biosimilar Market Size Forecast (2021-2026)
12.2.1 North America: Remicade Biosimilar Sales Forecast (2021-2026)
12.2.2 North America: Remicade Biosimilar Revenue Forecast (2021-2026)
12.2.3 North America: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
12.3 Europe Remicade Biosimilar Market Size Forecast (2021-2026)
12.3.1 Europe: Remicade Biosimilar Sales Forecast (2021-2026)
12.3.2 Europe: Remicade Biosimilar Revenue Forecast (2021-2026)
12.3.3 Europe: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Remicade Biosimilar Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Remicade Biosimilar Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Remicade Biosimilar Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Remicade Biosimilar Market Size Forecast by Region (2021-2026)
12.5 Latin America Remicade Biosimilar Market Size Forecast (2021-2026)
12.5.1 Latin America: Remicade Biosimilar Sales Forecast (2021-2026)
12.5.2 Latin America: Remicade Biosimilar Revenue Forecast (2021-2026)
12.5.3 Latin America: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Remicade Biosimilar Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Remicade Biosimilar Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Remicade Biosimilar Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Remicade Biosimilar Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Remicade Biosimilar Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Remicade Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
